ライフサイエンスコーパス: mild case

1 Norway3568 virus, which was isolated from a mild case.

2 nificantly higher in severe as compared with mild cases.

3 xpression was upregulated in both severe and mild cases.

4 rders among US adolescents is largely due to mild cases.

5 ing in identification of a growing number of mild cases.

6 ion period for which may differ from that of mild cases.

7 munolabeling appeared indistinguishable from mild cases.

8 s common in our population, especially among mild cases.

9 al loads have not seen as large a benefit as mild cases.

10 ereas M2-polarized monocytes predominated in mild cases.

11 structive pulmonary disease as compared with mild cases.

12 dometriosis cases are tested against minimal/mild cases.

13 isease was high (90.4% and 100%) and low for mild cases (66.2%), while the specificity was high for m

14 ized), and the Omicron variant (moderate and mild cases), along with COVID-negative controls.

15 ncluding selecting observational therapy for mild cases and attempting to maximize renal function in

16 M S variables differed significantly between mild cases and moderate to severe cases: median clotting

17 Mild cases are the most controversial as the risk of pat

18 inate severe cases from healthy controls and mild cases (area under the curve (AUC): 1 and 0.88, resp

19 ealthy controls as well as hospitalized from mild cases (AUC > 0.9).

20 y IgA titers quickly decreased after 6 wk in mild cases but remained detectable until at least week 1

21 vere, 3.2% serious, 8.7% moderate, and 16.0% mild case categories.

22 The number of mild cases could not be estimated.

23 Thus, mild cases (DOA2) show significant macular RGC loss as o

24 les in peripheral immune cells compared with mild cases during the first weeks after disease onset.

25 TE is the only method to differentiate mild cases from those with significant fibrosis.

26 In mild cases, higher proportions of SARS-CoV-2-specific CD

27 In mild cases (i.e., Braak stages I and II), the most inten

28 Improved surveillance approaches to capture mild cases in humans and to further cover rodent populat

29 Retention of mild cases in the DSM is important to represent the fact

30 uminal narrowing on cardiac catheterization, mild cases <50% narrowing, and controls were free of art

31 ntrol (C) asymptomatic (A), nonhospitalized (mild cases-M), and hospitalized (severe cases-S) groups.

32 should include recognition that treatment of mild cases might prevent a substantial proportion of fut

33 r these cases, when compared to moderate and mild cases not in ICU (n = 37), SeptiCyte RAPID had AUC

34 diate Uveitis (IU), their natural history in mild cases not necessitating treatment and their respons

35 A B-variant mutation reported in a mild case of Bartter disease was found to render the cot

36 This was due mainly to the contribution from mild cases of alopecia areata [OR 1.48 (0.96, 2.29)], su

37 ame deletions in the dystrophin gene lead to mild cases of BMD, truncations within the N-terminal act

38 patients with severe/critical illness versus mild cases of COVID-19 infection.

39 anges in the T-cell repertoire following two mild cases of COVID-19.

40 e are concerned that CTA or MRA may overlook mild cases of DSA-detectable FMD.

41 itially antibody-positive HHCs suggests that mild cases of Ebola virus infection occurred and that th

42 Mild cases of keratoconus were more prone to be explante

43 NS11021 in a number of LSDs including NPC1, mild cases of mucolipidosis type IV (ML4) (TRPML1-F408),

44 e risk for infection and was associated with mild cases of thrombocytopenia and neutropenia, none of

45 ascertainment bias may therefore exist, with mild cases or asymptomatic infections going undetected.

46 t in 8 (10.4%) severe cases than in 6 (4.2%) mild cases (P < 0.05), and was observed in 5/70 (7.1%) p

47 nct immune signatures separating severe from mild cases provide a foundation for developing targeted

48 Decisions about treating mild cases should be based on cost-effectiveness not cur

49 the DSM system is overly inclusive and that mild cases should be excluded from future DSM editions.

50 re used to compare 15 severe OM cases with 9 mild cases (single episode of acute OM recorded over 3 c

51 renatal visits may help appropriately direct mild cases to noncardiac centers.

52 vere cases was 63.89%, while specificity for mild cases was 78.57%.

53 otypes and moderate forms of adRP, including mild cases, which could be underdiagnosed.

54 toms, and transmission from asymptomatic (or mild) cases, which we use to estimate the country-specif

55 3rd reduction occurs mainly in patients with mild cases, while the number of severe cases was similar

56 types, ranging from lethal cases at birth to mild cases with increased bone fractures.